GlassScriptPhysician profile
Brent DO Loftis
NPI 1639348683
$12,592.07
in general payments reported to CMS, 2019-2025
32 companies · $1,559 in 2025
The $1,559 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,127 · 2020: $1,807 · 2021: $1,545 · 2022: $1,961 · 2023: $2,744 · 2024: $1,849 · 2025: $1,559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,868 · Education: $284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,868.46 |
| Education | $283.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $2,504.14 | 2019-2025 | Tremfya, Simponi, Simponi Aria |
| Sun Pharmaceutical Industries INC. | $1,468.28 | 2020-2025 | Absorica Ld, Winlevi, Ilumya |
| Abbvie INC. | $1,226.48 | 2019-2024 | |
| Ucb, INC. | $1,222.44 | 2019-2025 | Bimzelx, Cimzia |
| Pfizer INC. | $1,088.65 | 2019-2024 | |
| Amgen INC. | $757.04 | 2019-2025 | Otezla, Otezla |
| Lilly USA, LLC | $692.17 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Arcutis Biotherapeutics, INC. | $624.17 | 2023-2025 | Zoryve |
| Genzyme Corporation | $551.99 | 2020-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $464.90 | 2020-2024 | Siliq, Jublia, Duobrii |
| Boehringer Ingelheim Pharmaceuticals, INC. | $411.63 | 2023-2025 | Spevigo |
| Genentech USA, INC. | $248.23 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $227.38 | 2019-2025 | |
| Vyne Pharmaceuticals INC. | $214.98 | 2020-2021 | |
| Janssen Scientific Affairs, LLC | $188.60 | 2020-2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $117.56 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $97.76 | 2024 | Sotyktu |
| Regeneron Healthcare Solutions, INC. | $90.86 | 2020-2025 | Libtayo, Dupixent |
| Leo Pharma INC. | $74.63 | 2019-2025 | Adbry, Spevigo |
| Bausch Health US, LLC | $46.08 | 2023 | Targretin |
| Celgene Corporation | $44.26 | 2019 | |
| Promius Pharma LLC | $36.99 | 2019 | |
| Biofrontera INC. | $27.20 | 2024 | Ameluz, Xepi, Bf-Rhodoled |
| Epi Health, LLC | $24.56 | 2020 | |
| Dermavant Sciences, INC. | $23.46 | 2023 | Vtama |
| Sanofi-Aventis U.S. LLC | $22.45 | 2020 | |
| Botanix Sb INC | $22.36 | 2025 | Sofdra |
| Merz North America, INC. | $18.87 | 2024 | |
| Galderma Laboratories, L.P. | $18.13 | 2020 | |
| Icad, INC | $13.35 | 2022 | |
| Dermira, INC. | $12.39 | 2019 | |
| Apyx Medical Corporation | $10.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Loftis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.